...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal

"Markets reaction...yawn.  It just gives credence to the notion that we are very tightly held, but certainly not closely followed"

Well, the research in this paper, as well as related research on BRD4 ChIP-Seq, has been presented at prior conferences. Publication in peer-reviewed journal is the final step in the dissemination of the research, not the first. Posters and abstracts for this research has been available for some time. Plus, this paper originally came out a week ago. So it is good news, but not surprising/novel news.

BDAZ

Share
New Message
Please login to post a reply